Poly Medicure Ltd

Poly Medicure Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.4, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after accounting for total debt, which could pose a liquidity risk.

In terms of profitability, the company's return on equity (ROE) is 4.65%, and its return on assets (ROA) is 3.68%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming its peers in terms of generating returns from its equity and assets.

The company's revenue is concentrated in the healthcare services and equipment segment, with no significant geographic diversification disclosed. This concentration may expose the company to specific market risks, particularly in the healthcare sector, where demand can be sensitive to regulatory changes and economic conditions.

Looking at the growth trajectory, the company's revenue has shown a positive trend, but the exact growth rate is not specified. The company's capital expenditure is negative, indicating that it is generating more cash from operations than it is spending on capital investments. This could suggest a focus on maintaining existing operations rather than expanding.

The risk assessment for Poly Medicure Ltd indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations. However, the low dilution risk suggests that the company is not likely to issue additional shares in the near term, which is a positive sign for existing shareholders.

Recent events and filings do not provide specific details on the company's operations or strategic initiatives. However, the company's financial performance and risk profile suggest that it is maintaining a stable position in the market. The company's focus on healthcare services and equipment aligns with the industry's growth trends, but it needs to improve its profitability to match industry standards.

Revenue grew 21.4% year-over-year to INR 16.7 billion in FY2025, demonstrating strong top-line expansion momentum.

Net income surged 31.1% to INR 3.4 billion, outpacing revenue growth and indicating significant operating leverage.

Operating margins of 21.3% rank in the top quartile among 335 medical equipment peers, highlighting superior profitability.

Analysts project 17.9% upside to a mean price target of INR 1,697.6, reflecting positive market sentiment.

Free cash flow improved 267.8% to INR 603.7 million, signaling a robust recovery in cash generation capabilities.

Return on equity of 4.65% remains modest despite high margins, suggesting capital efficiency may lag peer expectations.

Long-term debt increased to INR 1.8 billion in FY2025, indicating a rising leverage trajectory over the five-year period.

Medium liquidity risk flags suggest potential challenges in meeting short-term obligations or trading volume constraints.

Revenue INR 4.94B, +16,4% YoY; Operating income −18,7% YoY.

• ▍Revenue INR 4.94B, +16,4% YoY
• ▍Operating income −18,7% YoY
• ▍Net income −16,8% YoY
• ▍Net margin 14.4%

Revenue INR 4.41B, +16,6% YoY; Operating income +22,5% YoY.

• ▍Revenue INR 4.41B, +16,6% YoY
• ▍Operating income +22,5% YoY
• ▍Net income +34,3% YoY
• ▍Net margin 20.8%

Revenue INR 4.24B; Operating income INR 930.3M.

• ▍Revenue INR 4.24B
• ▍Operating income INR 930.3M
• ▍Net margin 20.1%

Revenue INR 4.20B; Operating income INR 944.7M.

• ▍Revenue INR 4.20B
• ▍Operating income INR 944.7M
• ▍Net margin 20.8%

Revenue INR 3.85B; Operating income INR 842.7M.

• ▍Revenue INR 3.85B
• ▍Operating income INR 842.7M
• ▍Net margin 19.2%

Revenue INR 3.78B; Operating income INR 803.8M.

• ▍Revenue INR 3.78B
• ▍Operating income INR 803.8M
• ▍Net margin 18.1%

Revenue INR 16.70B, +21,4% YoY; Operating income +25,3% YoY.

• ▍Revenue INR 16.70B, +21,4% YoY
• ▍Operating income +25,3% YoY
• ▍Net income +31,1% YoY
• ▍Free cash flow +267,8% YoY
• ▍Net margin 20.3%

Revenue INR 13.76B, +23,4% YoY; Operating income +42,5% YoY.

• ▍Revenue INR 13.76B, +23,4% YoY
• ▍Operating income +42,5% YoY
• ▍Net income +44,0% YoY
• ▍Free cash flow +161,2% YoY
• ▍Net margin 18.8%

Revenue INR 11.15B, +20,8% YoY; Operating income +31,0% YoY.

• ▍Revenue INR 11.15B, +20,8% YoY
• ▍Operating income +31,0% YoY
• ▍Net income +22,4% YoY
• ▍Free cash flow −228,5% YoY
• ▍Net margin 16.1%

Revenue INR 9.23B, +17,4% YoY; Operating income −4,7% YoY.

• ▍Revenue INR 9.23B, +17,4% YoY
• ▍Operating income −4,7% YoY
• ▍Net income +7,8% YoY
• ▍Free cash flow −76,3% YoY
• ▍Net margin 15.9%

Revenue INR 7.86B; Operating income INR 1.67B.

• ▍Revenue INR 7.86B
• ▍Operating income INR 1.67B
• ▍Net margin 17.3%